A new study calculated the economic cost of cancers around the world, helping policymakers allocate resources appropriately and enact policies to curb the increase in cancer-related death and disability.

Cancer is the leading cause of death worldwide, claiming the lives of nearly 10 million people every year. The incidence of the disease is on the rise due to population aging, smoking, alcohol consumption, unhealthy diets, sedentary lifestyles, and air pollution. Cancer not only harms human lives but also the economy – it inflicts a huge financial burden on countries through reduced productivity, labor losses, and investment reductions.

The health and economic burdens of cancers are recognized as an urgent matter, as demonstrated by President Biden’s reignition of the Cancer Moonshot initiative, the World Health Organization’s Global Action Plan for the Prevalence and Control of Noncommunicable Diseases, and the United Nations Sustainable Development Goals target 3.4 – reduce pre-mature mortality from non-communicable diseases by one-third through prevention and treatment by 2030. Despite this urgency, the global economic cost of cancers has not yet been comprehensively investigated.

To address this gap and help policymakers curb the increase in cancer-related death and disability, an international team of researchers set out to estimate the economic cost of 29 cancers in 204 countries and territories, covering most countries in the world. The study, published in the Journal of the American Medical Association (JAMA) – Oncology, used a comprehensive modeling framework estimating the macroeconomic cost of cancer in terms of lost GDP.

“Many of the current economic studies on cancer are static, missing out on the future consequences of current loss in labor and treatment costs,” says IIASA Economic Frontiers Program Director Michael Kuhn, who was a coauthor of the study. “Our work is pioneering in the sense that it estimates the macroeconomic cost of cancer using a model that embraces many of the economic adjustment mechanisms, incorporating changes in labor supply due to cancer mortality and morbidity, as well as the loss in capital investments related to treatment costs.”

The study estimated the global economic cost of cancers from 2020–2050 to fall around $25.2 trillion in international dollars (INT$, at constant 2017 prices), which is equivalent to an annual tax of 0.55% on global gross domestic product. The researchers also identified the type of cancers that incurred the highest economic burden with lung cancer leading the way followed by colon and rectum cancer, breast cancer, liver cancer, and leukemia.

The findings further indicate that the health and economic costs of cancers are distributed unevenly across countries, and regions. China and the United States face the largest economic costs of cancers in absolute terms, accounting for 24.1% and 20.8% of the total global burden, respectively. While the majority of cancer deaths occur in low- and middle-income countries, their share of the economic cost of cancers is only about half.

World map showing cancer type with the largest economic cost in 2020–2050 © CHen et al. (2023)

Cancer type with the largest economic cost in 2020–2050 for each country
(TBL: Tracheal, bronchus, and lung cancer)

“The four economically most damaging cancers are all amenable to primary and secondary preventions, such as smoking, diet, and alcohol interventions and increased screening,” notes Kuhn. “This reveals the large potential for policy interventions world-wide, which will help to curb the trade-off between the high disease burden and the high economic burden.”

The authors stress that investing in effective public health interventions to reduce the burden of cancers is essential for protecting global health and economic wellbeing.


Chen, S., Cao, Z., Prettner, K., Kuhn, M., Yang, J., Jiao, L., Wang, Z., Li, W., Geldsetzer, P., Bärnighausen, T., Bloom, D.E, Wang, C. (2022). The global economic cost of 29 cancers from 2020 to 2050: Estimates and projections for 204 countries and territories. Journal of the American Medical Association (JAMA) – Oncology DOI: 10.1001/jamaoncol.2022.7826


Wavelet coherence

27 September 2023

Social Media Intelligence Mining Tool

Introducing a Game-Changing Social Media Intelligence Mining Tool! The ASA/CAT Groups proudly unveil a groundbreaking tool that promises to redefine our understanding of public sentiment and discourse across digital landscapes. With support from contributors Hossein Hassani, Nadya Komendantova, Elena Rovenskaya, and Mohammad Reza Yeganegi, this cutting-edge innovation is set to transform the way we harness insights from platforms like X (formerly Twitter), Google, and news outlets.
Satellite image of crops and fields

21 September 2023

Using satellite data to enhance global food security

Accurate estimates and forecasts of crop area and yield play an important role in guiding policy decisions related to food security, especially in light of the growing impacts of climate change. IIASA researchers and colleagues highlight the value of integrating remote sensing and data sharing for timely agricultural information critical for food security and sustainability planning in a new paper.    
Plastic pollution on a beach with sea in background

19 September 2023

Turning the tide: Ghana's innovative approach to tackle marine plastic pollution with citizen science

Working with IIASA researchers, Ghana has adopted a citizen science approach to addressing the problem of plastic pollution in marine environments, becoming the first country to integrate this type of data on marine plastic litter into its official monitoring and reporting processes. A new study presents this innovative approach on Ghana’s citizen science journey and offers a pathway that can potentially be adopted in other countries.